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Historical background
Rheumatologists have long known that the common
chronic arthropathies of childhood have both similarities
and differences from adult-onset rheumatoid arthritis
(RA), although it is also recognized that a few patients
with typical RA will present in childhood. Arthritis in chil-
dren is more heterogeneous than RA, and just as in RA,
the pathological basis for juvenile arthritis is being
explored with molecular techniques. In his 1966 Heber-
den oration, Professor Eric Bywaters noted among his
conclusions that every child has their own disease [1].
This truism is correct, but a great many similarities in
pathophysiology between children with the same clinical
phenotypes are increasingly being defined. These fea-
tures, including genetic markers, are different in many
respects from the adult counterparts, although, overall,
there are gross similarities (Table 1). This paper explores
these similarities and differences in childhood arthritis
compared with adult disease.
Classification of inflammatory arthritis in
children and adults
The classification of inflammatory arthritis occurring in chil-
dren and adults provide us some clues about the nature of
these diseases. The American College of Rheumatology
classification criteria uses the term ‘juvenile rheumatoid
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Chapter summary
The chronic arthropathies of childhood share clinical and pathological features with rheumatoid arthritis
(RA) in adults. Both are autoimmune diseases characterized by a destructive arthropathy. Both are
likely to be complex genetic traits, with autoantibodies and with a type-1-T-helper-cell cytokine profile in
disease tissues. In common with other autoimmune diseases, both have associations and linkage with
human keukocyte antigen (HLA) genetic markers. However, there are also important points of
distinction outlined in this chapter, which include substantial differences in clinical phenotype. Juvenile
rheumatoid arthritis (JRA) is characterized by several subtypes, whereas RA is more homogeneous.
There are differences in outcome: adults with RA tend to have a poorer outcome; in JRA, the outcome
is more variable and can be predicted by phenotypes at presentation. In addition, patients with RA
have a stronger family history of RA although both RA and JRA share an increased frequency of family
history of other autoimmune diseases. The genetic markers present to variable degrees in the subtypes
of JRA differ quite considerably from those of RA. This is particularly so with respect to HLA.
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arthritis’ (JRA), which includes JRA of pauciarticular, poly-
articular and systemic onset [2]. The European classification
uses the term ‘juvenile chronic arthritis’ (JCA), which
includes polyarticular arthritis, pauciarticular arthritis, sys-
temic arthritis, juvenile ankylosing spondylitis, psoriatic
arthritis and arthritis associated with inflammatory bowel
disease. The more recent International League Against
Rheumatism classification of ‘juvenile idiopathic arthritis’
(JIA) has seven subsets, including the spondyloarthro-
pathies [3]. The very fact that there are different classifica-
tion criteria, and each classification scheme has several
subtypes, suggests that juvenile arthritis is not a single
entity with uniform clinical, laboratory and immunogenetic
features. (While we have used the term JRA, the text
reflects the different terminology used by the authors cited.)
The revised American Rheumatism Association criteria for
RA, proposed in 1987, state that patients fulfilling any four
of seven criteria fulfill the requirement for RA [4]. The terms
‘classic’ (or ‘definite’) RA and ‘probable’ RA were removed.
Thus, RA in adults appears to be a single disease with dif-
ferent manifestations, while patients with one subtype of
JRA clearly differ from patients with the other subtypes.
There are, however, similarities between some types of
JRA/JIA and adult RA. Cassidy et al. studied children
referred to the University of Cincinnati between 1958 and
1978 [2]. In all, 10% of all patients with JRA, and 20% of
patients with polyarticular onset JRA were positive for
rheumatoid factor (RF) by sheep cell agglutination titer.
The authors found that those children that were initially
RF-positive, or later became RF-positive, were likely to be
older, female, more likely to be antinuclear-antibody-
positive and have more small-joint involvement of the
hands, whether their onset was polyarthritis or oligoarthritis.
These children were more likely to have joint erosions and
to experience a polyarthritic course. Thus, RF-positive
polyarticular JRA is the subtype that most likely represents
the occurrence of RA in a child and as such does not
differ much from the adult form. This type probably
accounts for about 5% of children with chronic arthritis.
Systemic onset JRA, the subtype of JRA that resembles an
infectious process, is characterized by fever and rash at
onset and is accompanied or followed by arthritis. Adult-
onset Still’s disease is the adult counterpart of systemic
onset JRA. The spondyloarthropathies occurring in children
Table 1
Similarities and differences between RA and JRA/JIA
Feature RA JRA/JIA
Classification criteria Single disease with different manifestations Phenotypically and genetically distinct subtypes
Gender Females > males Females > males except in systemic arthritis
Age of onset Puberty plus; peak 4th to 5th decade  Polyarticular: throughout childhood; 
peak 1–3 years of age
Pauciarticular: early childhood; peak 1–2 years of 
age
Systemic: throughout childhood; no peak
Extended multiplex families Present Very rare
Family history of other autoimmune disorders Present Present
Typical ocular involvement Keratoconjunctivitis sicca Chronic anterior uveitis
Prevalence 10/1000 0.86/1000
Ethnic distribution Reported in all populations EOPA is rare in non-Caucasians
HLA association HLA DRB1*0401, 0404, 0101 EOPA: HLA-A2, -DR5, -DR8, -DPB1*0201. 
in Caucasians (HLA-DR4 is protective)
Late pauciarticular: HLA-B27
Polyarticular: HLA-DR1, -DR4
Shared epitope Defined; amino acid positions 67–74  Not described
of third hypervariable region
Growth/developmental issues Rare Common
Pathophysiology Th1-mediated disease Th1-mediated disease 
(Pauciarticular: Also Th2-mediated)
Autoantibodies IgM RF common IgM RF rare
Natural history Majority have long-term disability Fewer than half have long-term disability
EOPA, early-onset pauciarticular arthritis; HLA , human leukocyte antigen; JIA, juvenile idiopathic arthritis; JRA, juvenile rheumatoid arthritis; RA,
rheumatoid arthritis; RF, rheumatoid factor; Th, T helper.S305
resemble their adult counterparts as well. However, one of
the distinct subtypes of inflammatory arthritis in children is
pauciarticular JRA, especially those with early-onset pau-
ciarticular arthritis (EOPA). EOPA is distinct not only from
RA in adults, but also from the other subtypes of JRA in
children. An adult counterpart of EOPA has not been
described and this subtype of JRA is unique to childhood.
In addition to classifying of patients into various distinct
phenotypic groups, the classification criteria also help to
predict long-term outcome, on the basis of the phenotype
at onset. A summary of published outcome studies found
that over 30% of JRA patients had significant functional
limitations after 10 or more years of follow-up [5]. Overall,
patients with pauciarticular JRA had better articular out-
comes, erosions being seen in 28% in a longitudinal
study, versus 45% of patients with systemic JRA and 54%
of the patients with polyarticular JRA [5].
However, a recent study by Guillaume et al. suggests that
oligoarticular-onset JRA is a more severe disease than
previously thought. After 6 years of follow-up of 207
patients with oligoarticular JIA, the probability of a poly-
articular course was 50%, of joint erosion, 35%, of uveitis,
30% and of remission, 23% [6]. In this study, gender and
age at onset were not identified as predictive of a poor
articular outcome. A population-based outcome study of
JCA from Sweden reported that at onset of the disease,
gender is the greatest predictor of disability and that at
follow-up, continued disease activity, followed by the pres-
ence of IgM-RF, are the greatest predictors of disability
[7]. Interestingly, those whose monoarticular or pauciartic-
ular disease extended later to polyarticular disease were
as frequently classified into Steinbrocker functional
classes II to IV as those who had polyarthritis at onset. In
one study, patients with intermittent or persistent systemic
JRA had poorer functional outcomes than those with a
monocyclic course [8]. Another group reported that a pol-
yarticular pattern and hip involvement at 6 months pre-
dicted a poor outcome in patients with systemic-onset
JRA [9]. More recently, Zak and Pedersen reported that
37% of patients had active JCA 26 years after onset, 11%
were in functional class III or IV and 22% had undergone
surgery related to their JCA [10].
Although recent developments in medical and surgical
treatments have improved the long-term outcome of
patients with RA, an 8-year follow-up study of patients
with seropositive RA showed that only 24% of patients
had no progression in the radiological destruction of the
joints of hands and feet [11]. Disease activity strongly
influences functional capacity in RA, even in long-standing
disease. After 12 years of follow-up in another study,
disease activity was the main determinant of the functional
status as measured by the Health Assessment Question-
naire score [12]. Several studies have reported increased
mortality rates in RA patients, with infections, pulmonary
and renal disease and gastrointestinal bleeding being the
major causes of death [13]. Patients with extra-articular
RA had higher mortality rates than not only an age-
matched general population, but also than the non-extra-
articular RA group in another study [14]. Overall, JRA
patients appear to have a better long-term outcome than
do patients with RA.
Epidemiology of inflammatory arthritis in
children and adults
The prevalence of definite RA among adults in the USA
has been estimated to be approximately 10 per 1000, with
an overall prevalence of 7 per 1000 for men and 16 per
1000 for women [15]. Thus, RA is a fairly common auto-
immune disease occurring in approximately 1% of the
adult population in the USA. The prevalence of JRA,
however, is considerably lower, estimated to be between
57 to 113 per 100,000 children under the age of 16. The
lifetime prevalence of JRA in a Mayo clinic (Rochester, MI,
USA) population was 86.1 per 100,000 [16]. The inci-
dence of JRA is estimated to be approximately 10 per
100,000 per year in children under 16 years of age. Thus
JRA is a much less frequent autoimmune disease than its
adult counterpart. Like RA, both pauciarticular and pol-
yarticular JRA are characterized by a female-to-male ratio
greater than 1. Systemic JRA, on the other hand, has no
such female predilection. Both RA and JRA have been
reported to occur in various populations of the world.
While RA does occur in non-Caucasians, at least one type
of JRA, EOPA, is relatively absent in non-Caucasians [17].
A meta-analysis of the epidemiology of JRA found that the
predominant subtype is polyarticular JRA in Black, East
Indian and Canadian aboriginal populations. In contrast,
EOPA is the most frequent subtype in Caucasian popula-
tions both in Europe and North America [18].
Family history of autoimmune disorders
Patients with RA frequently have a positive family history of
RA. In fact, several extended families with RA have been
reported and there are many affected sibling pairs with
RA. The availability of such affected sibling pairs has been
conducive to the performance of at least three genome-
wide scans of linkage in RA [19–21]. Although there are
studies that report an increased prevalence of inflamma-
tory arthritis among relatives of patients with JRA [22,23],
a family history of inflammatory arthritis is less common in
children, and extended multiplex pedigrees are extremely
rare in JRA. Only about 300 affected sibling pairs with
JRA are estimated to be in the USA [24], and about 180
of them have been entered into a Registry at Cincinnati
Children’s Hospital Medical Center (Cincinnati, OH).
Relatives of patients with RA have an increased preva-
lence of other autoimmune disorders besides inflammatory
arthritis [25,26]. Thomas et al. described a significantly
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higher prevalence of insulin-dependent diabetes mellitus
(IDDM) and autoimmune thyroiditis among first- and
second-degree relatives of patients with RA than in
patients with degenerative arthritis [25]. Similarly, Lin et al.
found that 7.8% and 2.8% of first-degree relatives of RA
probands had autoimmune thyroid disease and IDDM,
respectively, versus prevalences of 1% and 0.35% in the
general population [26].
Case reports describe JRA patients with other auto-
immune disorders such as type 1 diabetes mellitus,
vitiligo, thyroiditis and autoimmune oophoritis. In an epi-
demiological study, we have shown that the relatives of
patients with JRA have an increased prevalence of auto-
immunity [27]. Information was collected from interviews
of 110 patients with JRA, 23 families of affected sibling
pairs and 45 healthy controls. Information was available on
more than 1900 relatives. Overall, the relatives of JRA
patients had a significantly increased prevalence of
autoimmunity. The most frequent autoimmune disorder
seen was Hashimoto’s thyroiditis. The prevalences of RA
among relatives of patients with simplex JRA and controls
were not significantly different. Relatives of JRA-affected
sibling pairs also had a higher prevalence of autoimmunity
than controls. While there were no differences in the
overall prevalences of autoimmunity among relatives of
simplex and multiplex JRA families, the prevalence of
inflammatory arthritis (JRA, ankylosing spondylitis and RA
combined) was increased among the relatives of JRA-
affected sibling pairs.
Genetic factors
The most extensively studied susceptibility locus for
autoimmune disorders is the major histocompatibility
complex (MHC) located on chromosome 6p. This region is
densely packed with more than 200 genes [28] and
several of these are essential to the immune system,
including the human leukocyte antigen (HLA) genes. The
genes of the MHC in general, and the HLA genes in par-
ticular, are highly polymorphic. Studies have consistently
shown associations between HLA and several auto-
immune diseases, including both RA and JRA. The HLA
region is thought to account for half of familial cases of RA
[29]. HLA associations are distinct for RA and JRA,
demonstrating that the immunogenetic factors involved in
susceptibility to these two diseases are indeed different.
The class II HLA molecule HLA DR4 is associated with
RA and is encoded by HLA DRB1*0401 and
DRB1*0404 alleles.  HLA DRB1*0101, which encodes
HLA DR1, is also associated with susceptibility to RA in
Caucasians. Other HLA DR alleles are associated with
disease susceptibility in other ethnic groups.
However, the various HLA alleles that are associated with
susceptibility to RA have a common determinant in the
third hypervariable region of the DRB1 chain, encompass-
ing the amino acid positions 67–74 [30]. This common
region, designated the shared epitope, is thought to play a
crucial role in the interaction of the T cells with the peptide
HLA complex. Those RF-positive RA patients with severe
disease, with erosions and extra-articular features, are
more likely to carry two DRB1 susceptibility loci alleles
than are patients with milder forms of the disease [31].
Recently de Vries et al. studied 167 Caucasian RA
patients and 166 controls [32]. They confirmed the asso-
ciation of susceptibility to RA with alleles encoding the
susceptibility sequences of the shared epitope. They also
showed that some alleles, including DRB1*07,  *1201,
*1301 and *1501, showed significant protective effects.
Interestingly the protective alleles also shared a third motif
in the hypervariable region. Independent homozygosity
effects were observed both for susceptibility and for pro-
tective alleles. This suggests that amino acid substitutions
at position 67–74 of the HLA-DRB1 molecule influences
the HLA-associated risk (both susceptibility and protec-
tion) of RA.
JRA, like RA, also has associations with HLA. However the
different clinical subtypes of JRA themselves differ in their
HLA associations. For instance, the class I gene HLA-B27
has consistently been found to contribute risk for pauciar-
ticular JRA, especially among older males. HLA-DR1 and
-DR4, class II genes, have been reported to increase the
risk for polyarticular JRA. Much as in adults with RA, HLA-
DR4 is associated with RF-positive polyarticular disease in
older children. Interestingly, this gene might be protective
in patients with EOPA. In this subtype, combined class I
and II MHC associations are seen. Other MHC-encoded
genes such as LMP7 have also been shown to be associ-
ated with early-onset JRA [33]. HLA-A2, HLA-DR5, HLA-
DR8 and HLA-DPB1*0201 have all been shown to be
associated with JRA by several investigators, and interac-
tions between these alleles yield high odds ratios for
EOPA [34–39]. It is possible that in this type of JRA, four
individual genes (one HLA-A gene, two HLA-DR or DQ
genes and an HLA-DP gene) may be involved [24]. Con-
firming the associations that have been reported, linkage
between pauciarticular JRA and the HLA region has been
shown both by using transmission disequilibrium testing in
simplex families [40] and by allele sharing among affected
sibling pairs [41]. Similarly, linkage between polyarticular
JRA and the HLA region has also been shown by allele
sharing among affected sibling pairs [41].
One of the unique features of JRA is that there appears to
be a window of susceptibility, during which children with
predisposing HLA alleles or combination of alleles are
maximally susceptible to the development of JRA, sug-
gesting gene–gene and gene–environment interactions
[42]. In a study of 680 patients with JRA and 254 ethni-
cally matched, unrelated controls, we used survival analy-
sis to calculate the age by which 50% and 80% of
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children with particular HLA alleles and combinations of
alleles develop disease. Certain alleles were strongly
associated with early susceptibility to pauciarticular JRA,
including HLA-A2, -DR8, -DR5 and -DPB1*0201. Of the
children carrying at least one of these alleles, 50% had
disease onset before their third birthday. Among children
who carry HLA-A2 and any two HLA-DR alleles (HLA-
DR3, -DR5, -DR6, -DR8), the median age at onset of pau-
ciarticular disease was only 2.7 years. Combinations of
HLA-A2 and -DPB1*0201 and one DR allele narrowed
the window further to a median age at onset of 2.4 years.
Gender strongly influenced the age at which many of the
alleles have their effect. These results demonstrate the
complex interactions between different HLA susceptibility
alleles that influence the age of onset of JRA.
Several non-HLA susceptibility loci have been reported in
connection with both RA and JRA. For instance, the
macrophage-resistance gene NRAMP1 regulates activa-
tion of macrophages for enhanced expression of tumor
necrosis factor (TNF)-α, IL1-β and MHC class II. This gene
has been implicated in susceptibility to RA [43]. Associa-
tions between NRAMP1 and RA have been reported both
in Caucasian [44] and in Korean populations [45]. San-
jeevi  et al. showed that allele 3 of the NRAMP1 gene
increased the susceptibility of Latvian patients to JRA,
whereas allele 2 conferred protection [46]. Polymor-
phisms of the genes related to the cytokine network have
also been implicated in the pathogenesis of both JRA and
RA and these findings have been supported by associa-
tion studies.
The results of genome-wide scans from RA patients and
families, in addition to confirming the linkage between RA
and the HLA region, suggest the hypothesis that RA sus-
ceptibility loci overlap with loci implicated in other auto-
immune disorders. Cornelis et al. reported the first
genome scan in RA performed on 114 European RA
sibling pairs [19]. Linkage was significant only for HLA
and nominal for 19 markers in 14 other regions. Four of
these regions overlapped loci implicated in IDDM. In a
further study of a second set of families, linkage to one
region (3q13) was extended significantly. This non-MHC
locus could account for 16% of the genetic component of
RA. In another genome-wide scan for allele sharing in 309
RA-affected sibling pairs collected in the USA, significant
sharing was observed both within and outside the HLA
region [20]. This study confirmed the linkage of the HLA
locus to RA and revealed a number of non-HLA loci on
chromosomes 1, 4, 12, 16 and 17, with the significance of
evidence for linkage at P < 0.005. Not surprisingly, several
of the regions positive for linkage were found to overlap
with chromosomal locations implicated in other autoim-
mune disorders, including systemic lupus erythematosus,
psoriasis and inflammatory bowel disease. Myerscough et
al. tested for linkage and linkage disequilibrium between
IDDM susceptibility loci and RA [47]. Evidence for linkage
disequilibrium was found for a microsatellite marker at
IDDM8 and two markers at IDDM5.  Another genome-
wide scan performed on 252 affected sibling pairs with
RA from the UK confirmed the significant linkage to the
MHC region [21]. In addition, 11 non-HLA regions had
suggestive or nominal linkage. Six of these regions had
been previously identified in the other genome-wide scans
[19,20]. Genome-wide scans are under way in JRA and
have not yet been reported.
Clinical features
In general, the arthritis of RA is a symmetric polyarthritis.
The metacarpophalangeal and proximal interphalangeal
joints are typically involved in RA. Ulnar drift of the
metacarpophalangeal joint with volar subluxation is char-
acteristic of longstanding RA, which is accompanied by a
radial deviation of the wrist [48]. In JRA, any joint can be
affected, but large joints are most frequently involved.
Smaller joints of the hands and feet are involved in poly-
articular JRA. In longstanding arthritis of the wrist in JRA,
there is shortening of the ulna, which results in bowing of
the radius and in ulnar deviation of the wrist [49]. Charac-
teristic deformities of fingers, such as swan-neck defor-
mity and boutonnière deformity, can be seen in both RA
and JRA. Localized growth disturbances seen with JRA,
especially EOPA, most likely reflect the impact of arthritis
on the growing skeleton rather than a genuine difference
between juvenile and adult-onset arthritis. Involvement of
the shoulder and hip are less frequent early on in the
disease, both in RA and JRA.
Subcutaneous nodules occur in 20% of RA patients with
positive blood tests for RF. Rheumatoid nodules are
almost always confined to those children with polyarticular
JRA. Rheumatoid vasculitis, which occurs in adults with
RA, is rare in children and occurs most often in the older
child with RF-positive polyarthritis. The overall prevalence
of pericardial involvement in JRA is estimated to be around
3–9% [49] and such involvement is found only in children
with systemic-onset disease. In adults with RA, pericardial
involvement is more frequent, with echocardiographic evi-
dence of pericardial effusion or other pericardial abnormal-
ity seen in almost 50% of patients with RA who have no
clinical symptoms of cardiac involvement [50]. Felty’s syn-
drome is defined as RA in combination with splenomegaly
and leukopenia, characteristically occurring in patients
with longstanding, seropositive, nodular RA. An increased
risk for the development of lymphoproliferative malignan-
cies in patients with Felty’s syndrome has been reported
[31]. While lymphadenopathy and splenomegaly are char-
acteristic of systemic-onset JRA, Felty’s syndrome is only
uncommonly reported in JRA [51,52].
The common ocular manifestation of RA is keratoconjunc-
tivitis sicca. Chronic uveitis is rare in adults with RA. In
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children, however, keratoconjunctivitis sicca is rarely seen.
In one series only 3 of 131 children with chronic uveitis
developed keratoconjunctivitis [53]. Chronic nongranulo-
matous uveitis is one of the most devastating complica-
tions of JRA, responsible for visual loss in 11–30% of
children with uveitis in recent series [54–56]. On average,
uveitis has been described in 15–20% of patients with
pauciarticular JRA and in about 5% of those with polyartic-
ular JRA. Uveitis is rare in children with systemic onset
JRA.
Pathological features
The articular pathology of JRA shares features in common
with RA. Synovial biopsy specimens reveal villous hyper-
trophy and hyperplasia of the synovial lining. Cellular infil-
tration, predominantly with T lymphocytes, occurs early in
the disease. The inflammatory process eventually results in
progressive erosion and destruction of articular cartilage.
Joint destruction is thought to occur later in the course of
JRA than in adult disease [49]. The greater thickness of
the juvenile articular cartilage could account for this differ-
ence. Both RA and JRA are believed to be mediated by
the type 1 T helper (Th1) phenotype of lymphocytes
[57–59]. Wedderburn and Woo have shown that the ratio
of interferon (IFN)-γ:IL-4 production is much higher in syn-
ovial fluid T cells than in peripheral blood T cells in chil-
dren with JIA. This was due to a very high number of
IFN-γ-producing cells, both in the CD4 and CD8 popula-
tions. More recently, Scola et al. have demonstrated
similar cytokine findings in the more-difficult-to-obtain JIA
synovial tissues [60]. Similarly, Th1-related chemokine
receptors CCR5 and CXCR3 have been found in synovial
fluid [61] and also in synovial tissues (Scola et al., unpub-
lished). Cytokines that are involved in the inflammatory
process are also similar, including TNF-α and IL1,
enabling control of these responses by the use of appro-
priate, biologic disease-modifying agents. However, at
least in the case of pauciarticular JRA, Th2-mediated
inflammatory responses may have a role to play. Murray et
al. showed that synovial fluid from patients with pauciartic-
ular disease significantly overexpresses IL-4 messenger
RNA relative to synovial fluid from patients with polyarticu-
lar JRA and RA [62]. Thompson et al. documented CCR4-
bearing CD4 synovial fluid lymphocytes with a phenotype
that was Th2-like in that they produced greater IL-4 than
IFN-γ [63]. Raziuddin et al. found a distinctly enhanced
mixed-Th1/Th2-cell-response cytokine pattern in patients
with systemic JRA from Saudi Arabia [64].
Concluding remarks
Although there are similarities between the inflammatory
arthritides occurring in adults and children, RA and
JRA/JIA appear to be distinct phenotypically, except for
the older child with RF-positive polyarticular arthritis. Fur-
thermore, the various subtypes of JRA appear to be dis-
tinct entities and could represent different diseases with
distinct etiological and genetic factors. Paradoxically, clini-
cally distinct autoimmune disorders do appear to share
common genetic susceptibility factors, as has been shown
by Becker et al. [65]. In this context, it is plausible that
there are common genetic susceptibility factors that pre-
dispose an individual to an autoimmune disorder, with
other genetic (especially HLA) and/or environmental
factors that determine the type of specific disorder and its
manifestations.
Glossary of terms
EOPA = early-onset pauciarticular arthritis; HLA = human
leukocyte antigen; IFN = interferon; IL = interleukin; IDDM =
insulin-dependent diabetes mellitus; JCA = juvenile
chronic arthritis; JIA = juvenile idiopathic arthritis; JRA =
juvenile rheumatoid arthritis; MHC = major histocompati-
bility complex; RA = rheumatoid arthritis; RF = rheumatoid
factor; TNF = tumor necrosis factor; Th1 (Th2) = type 1
(type 2) T helper.
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